05:11:47 EST Sat 09 Nov 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:DVAX - DYNAVAX TECHNOLOGIES CORP - http://www.dynavax.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DVAX - Q0.111.83·13.100.513.01+0.998.25,099.765,39928,81012.50  13.72  12.4115.01  9.7418:58:52Nov 0715 min RT 2¢

Recent Trades - Last 10 of 28810
Time ETExPriceChangeVolume
18:58:52Q12.800.7824
17:52:25Q12.850.833,670
17:31:55Q12.800.781
17:15:58Q13.010.99176,800
16:27:49Q13.101.08150
16:27:31Q13.010.9951
16:27:24Q12.820.801
16:20:00Q13.010.99376
16:17:46Q13.101.0835
16:17:23Q13.091.07150

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-11-07 16:02U:DVAXNews ReleaseDynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates
2024-11-07 16:01U:DVAXNews ReleaseDynavax Announces $200 Million Share Repurchase Program
2024-10-29 08:30U:DVAXNews ReleaseDynavax Adopts Limited-Duration Stockholder Rights Plan
2024-10-24 16:10U:DVAXNews ReleaseDynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
2024-09-05 08:30U:DVAXNews ReleaseLantheus Appoints Julie Eastland as New Board Member
2024-08-06 16:01U:DVAXNews ReleaseDynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates
2024-07-23 16:00U:DVAXNews ReleaseDynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024
2024-06-27 16:09U:DVAXNews ReleaseDynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program
2024-05-28 16:15U:DVAXNews ReleaseDynavax to Present at Upcoming Investor Conferences
2024-05-14 08:30U:DVAXNews ReleaseDynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B(TM) Regimen for Adults on Hemodialysis in the U.S.
2024-05-08 16:01U:DVAXNews ReleaseDynavax Reports First Quarter 2024 Financial Results and Provides Business Updates
2024-04-24 16:05U:DVAXNews ReleaseDynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
2024-02-27 18:54U:DVAXNews ReleaseDynavax to Present at TD Cowen's 44th Annual Health Care Conference
2024-02-22 16:01U:DVAXNews ReleaseDynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance
2024-02-08 16:15U:DVAXNews ReleaseDynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024
2024-01-08 09:00U:DVAXNews ReleaseDynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
2024-01-03 18:33U:DVAXNews ReleaseDynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-11-20 17:04U:DVAXNews ReleaseDynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference